A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center, double-masked, randomized, placebo controlled parallel treatment conjunctival allergen challenge (CAC) study in patients with allergic conjunctivitis

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Greiner, Jack V., OD DO PhD
• Treatments: Fluticasone; Lubricant Eye Drops; Olopatadine Hydrochloride; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• At least 18 years of age & either sex, any race

• Willing and able to follow all instructions and attend all study visits

• Positive history of ocular allergies

• Reproducible positive ocular allergic reaction induced by conjunctival allergen challenge

Exclusion Criteria:

• Have planned surgery during trial period

• Female currently pregnant, planning a pregnancy, or lactating

• Use of disallowed medications